The Biology Behind Your Botox: What DNA Testing Reveals About Your Skin
It started as a small annoyance, tracked on the calendar. Ten weeks after Botox, the lines above the brows would begin creeping back. By week twelve, they’d fully resettled. A friend, treated at the same clinic with the same brand and roughly the same unit count, sailed through five months with zero top-up needed.
Then came a second clue. After a minor surgical procedure, the general anaesthetic left one patient not just groggy but genuinely unwell weeks of mental fog and a recovery that dragged on twice as long as expected. Every doctor consulted offered some version of the same shrug: “some people just process things differently.” Unsatisfied with that answer, she went looking for the real why and found it in her DNA. The same test that explained her slower Botox breakdown also revealed why her body handled anaesthetic differently, along with a map of the diseases she may be predisposed to.
Stories like this are exactly why DNA testing is becoming one of the most exciting shifts in modern aesthetics. For decades, skincare and aesthetic treatments have been built around one big assumption: that what works for most people will work for you too. But your skin doesn’t follow a population average, it follows your own biology.
At Biolite Clinic Dubai, Dr. Nathan Curran, our longevity and functional medicine physician, explains it simply: most skincare advice is designed for “what works for most people, most of the time.” The problem is, your skin was never designed to be average.
Through genetic testing, we can now look beneath the surface and identify the variants that actually shape how your skin behaves, how quickly it breaks down collagen, how efficiently it manages oxidative stress, and how strongly your inflammatory pathways react to triggers. As Dr. Curran puts it, these markers aren’t just abstract data points, they’re the systemic drivers behind the biological environment your skin is ageing within.
He calls this internal environment your “terrain.” The idea is that what shows up on your face is often just a readout of processes already happening deeper in the body. Fine lines, dullness, pigmentation, texture Dr. Curran describes the skin as a dashboard, giving a real-time picture of what’s going on systemically.
This is also why the Botox question finally makes sense. It’s not that one person’s body is “better” at holding a neurotoxin than another’s; the starting terrain is simply different. Two patients can use the same product, the same protocol, and walk away with completely different outcomes, because the result depends as much on the biological terrain the treatment is applied to as it does on the treatment itself and genetics plays a significant role in shaping that terrain.
Collagen-stimulating treatments make the point even clearer. Someone carrying variants in the COL1A1 gene, which is linked to faster collagen degradation, may see a much more modest response from microneedling than someone without that variant even with an identical session.
This is the foundation of personalised aesthetics at Biolite: using precision diagnostics, including DNA and skin DNA testing, to build a treatment plan around your unique biological terrain rather than a generic protocol. From collagen turnover to antioxidant defence to sun sensitivity, your genetic blueprint gives us a roadmap most skincare routines simply don’t have.
Because when your treatment plan is built around your biology, results stop being a guessing game.
Want the full story? Read more in our feature with GRAZIA Magazine.
https://graziamagazine.com/me/articles/dna-testing-beauty/
